Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors-Reference-Cited by-同舟云学术

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

Published:2009-08 Issue:4 Volume:9 Page:302-306
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Dimopoulos Meletios A.,Roussou Maria,Gavriatopoulou Maria,Zagouri Flora,Migkou Magdalini,Matsouka Charis,Barbarousi Despina,Christoulas Dimitrios,Primenou Erasmia,Grapsa Irini,Terpos Evangelos,Kastritis Efstathios

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference21 articles.

1. Pathogenesis and treatment of renal failure in multiple myeloma;Dimopoulos;Leukemia,2008

2. Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function;Jagannath;Cancer,2005

3. Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study;Chanan-Khan;Blood,2007

4. Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study;San-Miguel;Leukemia,2008

5. Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens;Roussou;Leuk Lymphoma,2008

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma;2024-03-04

3. Pomalidomide Use and Kidney Outcomes in Patients with Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study;2024

4. Bendamustine, prednisone and bortezomib (BPV) induction therapy prior autologous stem cell transplantation (ASCT) in 135 newly diagnosed multiple myeloma patients: comparison between patients with normal and impaired renal function;2023-12-11

5. Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report;BMC Nephrology;2023-07-06